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Abstract The amino acid sequence of Rnalp, a yeast protein 
implicated in the maturation and/or nucleocytoplasmic transport 
of RNA, is characterised by the presence of eight leucine-rich 
repeats (LLRs) as well as two intervening repeats of a different 
type and a highly acidic C-terminal region. Limited proteolysis 
of purified Rnalp expressed recombinantly in bacteria reveals 
that the C-terminal extension but not the region containing the 
two types of repeats is highly accessible to proteolytic attack and 
that the C-terminal region most likely harbours (a) low affinity 
Ca2+-binding site(s). These results are indicative of the domain 
structure of the Rnalp molecule, with the repeats and the C- 
terminal region being accessible for different interactions. 
Key words: Leucine-rich repeat; Nucleocytoplasmic transport; 
RNA1 mutant; RNA processing 
1. Introduction 
The rna mutants of the yeast Saccharomyces cerevisiae are 
defined as a set of thermosensitive mutant strains in which the 
production of RNA is affected after the shift to the restrictive 
temperature [1]. While the rna2-11 mutants are impaired in the 
proper processing of pre-mRNA (for review see [2]) the rnal 
mutant is an exception as it shows pleiotropic defects in the 
production of all major classes of RNA and in the nucleocyto- 
plasmic transport of mRNA (for review see [3]). 
Although the phenotypic onsequences of a conditionally 
lethal mutation in the RNA1 gene have been described in detail, 
the precise function of its product is not known. Likewise, the 
structural and biochemical information on the Rnal protein is 
so far limited to the respective cDNA and/or genomic se- 
quences from S. cerevisiae [4], Schizosaccharomyces pombe [5], 
mice [6] and Caenorhabditis elegans [7], and to a purification 
protocol for S. pombe Rnalp [5]. Internal homology searches 
revealed that the deduced amino acid sequences of all Rnal 
proteins how a pronounced repeat structure with a leucin-rich 
motif of 29 amino acids repeated eight times along the polypep- 
tide chain [5,6,8]. These leucine-rich repeats (LRRs), which are 
characterised by regularly spaced hydrophobic, predominantly 
leucine residues, are present in a number of proteins otherwise 
diverse in function and cellular localisation, e.g. the RNase 
inhibitor [9], adenylyl cyclase [10], the toll membrane receptor 
of Drosophila melanogaster [11], and the product of the disease 
resistance gene RPS2 of Arabidopsis thaliana [12]. It is generally 
assumed that LRR motifs are involved in mediating highly 
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specific protein-protein teractions, although candidates for 
LRR protein ligands have only been identified in a few cases, 
e.g. the dis2 protein phosphatase which physically interacts 
with the LRR protein sds22 of S. pombe [13] and RNase which 
forms a tight stoichiometric complex with the RNase inhibitor 
[14]. 
The recently determined crystal structure of the porcine 
RNase inhibitor provided the first detailed information on the 
three-dimensional fo ding of LRRs [15]. Here, the individual 
repeats constitute fl-~ structural units with the side chains of 
the conserved leucines or other aliphatic residues forming the 
hydrophobic ore of the protein. The entire protein has the 
non-globular shape of a horseshoe with the a-helices of the 
LRRs aligning on the outer circumference and the fl-strands 
forming a curved parallel fl-sheet on the inner circumference. 
Although the lengths of the repeats and the spacing of some of 
the hydrophobic residues vary slightly between the repeats in 
different LRR proteins it seems likely that similar fl-c~ struc- 
tures occur in all proteins containing LRRs [16]. It is, however, 
impossible to deduce the general folding of LRR proteins from 
the structure of the RNase inhibitior as the number of individ- 
ual repeats differs drastically between different proteins. More- 
over, while the RNase inhibitor is composed exclusively of 
LRRs, other members of this group of proteins contain addi- 
tional sequences (for review see [16]). In the case of the Rnal 
protein, the LRRs are interrupted after the first and third 
repeat by segments of 36 amino acid residues also showing 
homologies with one another. In addition, a unique C-terminal 
extension differing in length between the Rnal proteins from 
yeast, C elegans and mouse follows the last LRR [5 7]. To 
analyse whether these non-LRR sequences/domains in Rnalp 
are particularly accessible in solution, thus enabling them to 
engage in specific interactions and/or functions, we subjected 
recombinantly expressed Rnalp from S. pombe to a series of 
limited proteolysis tudies. Immunoblotting with domain-spe- 
cific antibodies and N-terminal protein sequence analysis of 
proteolytic fragments revealed that the C-terminal extension of 
Rna 1 p is highly accessible to different proteases and most likely 
contains (a) low affinity Ca2+-binding site(s). 
2. Materials and methods 
2.1. Expression of Rnalp in E. coli and purification of the protein 
A BspMI-Xhol fragment of the S. pombe rnal gene [5] served as the 
DNA template for the amplification of the complete Rnalp cDNA by 
PCR. Oligonucleotide Ol (5'-CTTTCAACAACGAATTCCATGTC- 
GCGT-3'), which introduced an EcoRI cleavage site upstream of the 
ATG start codon, was used as the sense primer, whereas oligonucleo- 
tide 02 (5'-CGGAAACAGCGCTGCAGGGTTCGAGAGGG-3'), 
which contained a Pstl cleavage site downstream of the stop codon, 
represented the antisense primer. The PCR product was gel-purified, 
cut with EeoRl and PstI, and cloned into the appropriately linearised 
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bacterial expression vector pkk223-3 (Pharmacia). The resulting plas- 
mid, pkkRnal, was used to transform E. coli JM 105 cells, and clones 
containing the plasmid were selected by growth on LB containing 0.15 
mg/ml ampicillin [17]. To verify that no mutations were introduced by 
the PCR reaction, the rnal cDNA insert in pkkRnal was sequenced 
completely following the dideoxy method [18]. The expression of re- 
combinant Rnalp in E. coli JM 105 cells containing the pkkRnal 
plasmid was verified by analysing total protein extracts of bacteria, 
which were grown overnight in LB containing 0.15 mg/ml ampicillin 
and 1 mM IPTG, in immunoblots using a Rnalp-specific antibody [5]. 
E. coli cells containing pkkRnal were grown at 37°C in 500 ml LB 
containing 0.15 mg/ml ampicillin and expression of the rnal gene was 
induced by the addition of l mM IPTG at late-log phase. Cells were 
collected by centrifugation (20 min, 5000 x g, 4°C) and washed once in 
ice-cold phosphate-buffered saline. The cell pellet was then resuspended 
in 7 ml buffer A (30 mM Tris-HC1, pH 7.5, 150 mM NaC1, 2 mM MgCI> 
1 mM DTT, 1 mM PMSF) and homogenised using a French press. 
Three vols. of buffer A were added to the homogenate and the resulting 
suspension was clarified by centrifugation (20 min at 10,000 × g, fol- 
lowed by 60 min at I00,000 x g, 4°C). Ammonium sulfate was added 
to the lysate to 60% saturation and precipitated proteins were removed 
by centrifugation. The resulting supernatant was dialysed against buffer 
B (20 mM Tris-HC1, pH 7.5, 50 mM NaC1, 1 mM DTT, 1 mM PMSF) 
and chromatographed on a DE-52 (Whatman) column which was de- 
veloped with a linear gradient of 0 to 1 M NaCI in buffer B. Fractions 
containing Rnalp were identified by immunoblotting with a Rnalp- 
specific antibody, pooled, dialysed against buffer B, and applied to a 
Mono Q column connected to a fast-performance liquid chromatogra- 
phy (FPLC) system (Pharmacia). The column was washed with buffer 
B containing 250 mM NaCI and then developed with a linear salt 
gradient (0.25-1 M NaC1) in buffer B. Rnalp-containing fractions 
eluting at approximately 0.5 M NaC1 were pooled, dialysed against 
buffer B, and stored at 4°C. For long-term storage the protein was 
dialysed against buffer B containing 50% glycerol and then kept at 
-20°C. 
2.2. Limited proteolysis 
cc-Chymotrypsin and endoproteinase Asp-N treatment of purified 
Rnalp was carried out in buffer B with the protein concentration 
adjusted to 0.5 mg/ml and at an enzyme-to-substrate tio of 1 : 100 and 
1 : 150, respectively. Samples were incubated at room temperature and 
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the reaction was stopped after the time indicated by boiling in SDS 
sample buffer [19]. Reaction products were separated in SDS-12.5%- 
polyacrylamide g ls and either stained with Coomassie blue or sub- 
jected to immunoblotting [20]. To assess a potential effect of Ca 2*, 
equivalent digestions were carried out in the presence of 1, 2, 5 and 
10 mM CaC12, respectively. 
2.3. Antibodies 
Synthetic peptides corresponding in sequence to amino acids 36~9 
and 60~73 of S. pombe Rnalp, respectively, but containing an addi- 
tional cysteine at the N-terminus, were coupled to ovalbumin using the 
bifunctional cross-linker m-maleimidobenzoyl-N-hydrosuccinimide 
ester (MBS; Pierce) [21]. Rabbits were injected with the peptide-ovalbu- 
min conjugates as described [5] and peptide-specific antibodies were 
purified from the serum by affinity chromatography on the immobilised 
peptide [21]. The antibody directed against he C-terminal Rnal p pep- 
tide (amino acids 374-386 of S. pombe Rnalp) has been described [5]. 
For immunoblotting the affinity-purified antibodies were employed at 
a concentration of 2/2g/ml and visualised using peroxidase-coupled 
secondary antibodies (Dako) and a chemoluminescence-based detec- 
tion system (Amersham-Buchler). 
3. Results 
3.1. Expression and purification of recomb&ant Rnalp 
To obtain quantities of S. pombe Rna lp  sufficient for a 
detailed biochemical analysis the cDNA encoding the protein 
was amplified by PCR and cloned into the bacterial expression 
vector pkk223 under the control of the tac promoter. Expres- 
sion of the protein was induced by cultivating the transformed 
bacteria in the presence of IPTG as revealed by immunoblot 
analysis of a total bacterial ysate with a Rnalp-specific anti- 
body (not shown). 
Purification of the recombinant Rna lp  was achieved by em- 
ploying in a modified form a protocol developed for the isola- 
tion of the endogenous Rna lp  from S. pombe cells [5]. Because 
of the highly acidic nature of the protein (the isoelectric point 
for S. pombe Rnalp  is 4.3) ammonium sulfate fractionation 




Fig. 1. Purification of S. pombe Rnalp expressed in E. coli. The purification was carried out as described in section 2 and proteins present in the 
different fractions were analysed by SDS-PAGE. E. coli cells containing the expression plasmid pkkRnal were lysed using a French press and soluble 
proteins (lane 3) were fractionated by ammonium sulfate precipitation. Proteins soluble in the presence of 60% ammonium sulfate (lane 4) were 
dialysed against buffer B and chromatographed on a DE-52 column. Unbound material is shown in lane 5 whereas the Rnalp fraction, eluting at 
approximately 0.5 M NaCI, is given in lane 6. Final chromatography was performed on a Mono Q column and yielded highly purified Rnalp (lanes 
8 and 9 showing a peak fraction and the entire Rnal p pool after Mono Q chromatography, respectively; the flow-through fraction of the Mono Q 
column is given in lane 7). Authentic Rnalp purified from S. pombe and molecular weight markers are shown in lanes 1 and 2, respectively. 
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Fig. 2. Limited proteolysis of purified Rnalp. The protein was treated with endoproteinase Asp-N (upper panels, A-D) or ~-chymotrypsin (lower 
panels, E-H) for the times indicated. Reactions were stopped by boiling the samples in SDS-PAGE sample buffer. The products of the limited 
proteolysis were seperated in SDS-12.5%-polyacrylamide gels and either stained with Coomassie blue (A,E) or blotted to nitrocellulose and probed 
with antibodies directed against peptide P1 (C,G), peptide P2 (D,H) or the C-terminal Rnalp-peptide P3(B,F). Molecular weight markers with the 
apparent masses indicated are given in lane MW. Rnalp designates the unproteolysed protein. Note that both enzymes generate relatively stable 
fragments of 42.5 and 37.5 kDa, respectively, which have lost the C-terminal peptide. 
followed by two ion exchange chromatography steps led to the 
preparation of Rnalp which was at least 95% pure as judged 
by SDS-PAGE (Fig. 1). Following this procedure approxi- 
mately 0.2 mg Rnalp could be purified from a 500 ml bacterial 
culture. The pure protein was recognised by an antibody di- 
rected against a synthetic peptide corresponding in sequence to 
the C-terminal 12 amino acid residues of S. pombe Rnalp (not 
shown). Moreover, when analysed in analytic gel filtration and 
sucrose velocity gradients the recombinant Rna 1 p has the same 
hydrodynamic properties as authentic Rnalp from 
S. pombe (not shown). These data indicate that Rnalp ex- 
pressed in bacteria most likely has the same general folding as 
the authentic protein synthesised in S. pombe cells. 
3.2 Probing of the domain structure of  Rnalp by limited 
proteolysis 
The primary structure of both S. pombe and S. cerevisiae 
Rnalp is characterised by the presence of three principle se- 
quence elements. Eight leucine-rich repeats, each 29 amino 
residues in length, two intervening repeats of 36 amino acids 
which interrupt he otherwise continuous LRRs after the first 
and the third LRR, and a region C-terminally flanking the 
LLRs which is characterised by a stretch of acidic amino acids 
followed by a short amphiphatic s-helix at the C-terminus [5]. 
To analyse whether these sequence lements also form distinct 
structural domains in the folded molecule we subjected purified 
Rnalp to a series of limited proteolysis studies and character- 
ised the resulting fragments by immunoblotting with three dif- 
ferent peptide-specific antibodies. The sequence segments re- 
cognised by these antibodies reside in the first LRR (amino 
acids 3649, peptide P1), the first intervening repeat (amino 
acids 60-73, peptide P2), and the C-terminal helix (amino acids 
374-386, peptide P3), respectively. 
We first employed endoproteinase Asp-N which has a speci- 
ficity for aspartate and thus was the preferable enzyme to char- 
acterise the accessibility of the aspartate-rich C-terminal exten- 
sion. The time-course shown in Fig. 2A reveals that Asp-N 
cleavage generates a stable 42.5 kDa fragment, which is already 
apparent after 1 min of digestion. Five minutes of proteolysis 
converts the intact Rnal p almost completely into the 42.5 kDa 
product which then remains table for at least 1 h. Immunoblot- 
ting with the three antibodies reveals that only anti-P1 and 
anti-P2 but not anti-P3 recognise the 42.5 kDa product of the 
limited Asp-N digestion (Fig. 2B-D). This analysis clearly indi- 
cates that Asp-N cleavage removes the very C-terminal end of 
the protein, with the hydrolysis most likely occurring in the 
stretch of acidic amino acids present in the C-terminal exten- 
sion. A highly similar proteolysis pattern is obtained when 
endoproteinase Glu-C, an enzyme cleaving C-terminally to 
both aspartate and glutamate, is employed (not shown). 
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Fig. 3. Effect of Ca 2÷ on the stability of Rna 1 p towards a-chymotrypsin. Purified Rna 1 p was subjected to 30 min a-chymotrypsin treatment asoutlined 
in section 2. The reaction was carried in the presence of 0, 1, 2, 5 or 10 mM Ca 2+ and products were analysed by SDS-PAGE and Coomassie staining 
(A) or immunoblotting with the antibody directed against peptide P1. Note that the stability of the protein against chymotryptic attack is increased 
in the presence of elevated Ca z+ concentrations. 
Limited proteolysis with a-chymotrypsin, which cleaves C- 
terminally to aromatic and also other hydrophobic amino 
acids, yields a major fragment of around 37.5 kDa (Fig. 2E). 
This product is already apparent after 1 min of digestion and 
remains relatively stable throughout he next 60 min of c~- 
chymotrypsin treatment. Only upon prolonged incubation with 
the enzyme does a 28 kDa fragment becomes visible in the 
SDS-PAGE analysis hown in Fig. 2E. Both chymotryptic frag- 
ments react with the anti-P1 and anti-P2 but not the anti-P3 
antibodies indicating that they represent C-terminally trun- 
cated versions of the protein (Fig. 2F-H). To corroborate this 
conclusion the fragments generated after 30 min of chymotryp- 
sin treatment were separated by SDS-PAGE, blotted to PVDF 
membrane and subjected to N-terminal sequence analysis. All 
polypeptides present, i.e. the intact 44 kDa protein as well as 
the 37.5 kDa and 28 kDa chymotryptic fragments, start with 
the sequence SRSF corresponding to amino acid residues 2-5 
of the Rnalp sequence ncoded by the S. pombe cDNA. This 
indicates that the starting methionine residue is removed post- 
translationally in E. coli and that the resulting N-terminal serine 
remains otherwise unmodified. In contrast, authentic Rnalp 
isolated from S. pornbe is N-terminally blocked to automated 
Edman degradation (data not shown). Taken together these 
data show that a-chymotrypsin generates table fragments 
lacking a part of the C-terminal but not the N-terminal se- 
quence. Moreover, the size of the major chymotryptic frag- 
ment, 37.5 kDa, indicates that the cleavage has occurred in the 
C-terminal extension close to the last LRR resulting in the loss 
of an approximately 7 kDa portion comprising most or all of 
the highly acidic stretch and the C-terminal helix. 
Previous tudies have indicated the presence of (a) low affin- 
ity Ca2÷-binding site(s) in S. pombe Rnalp [5]. To study 
potential effect of the binding of Ca 2+ on the stability of Rnalp, 
we performed the proteolysis described above in the presence 
of varying Ca 2÷ concentrations. Fig. 3 shows that the stability 
of Rnalp towards a-chymotrypsin (as revealed by the appear- 
ance of the 37.5 kDa fragment) is indeed increased provided 
that the Ca 2+ concentration exceeds 2-5 mM. Similarly, the 
generation of the 42.5 kDa fragment is markedly retarded if a 
limited Asp-N proteolysis is carried out in the presence of 
10 mM Ca 2+ (not shown). As the activity of the two proteases 
is not significantly affected by Ca 2+, the proteolysis patterns 
indicate that the increased stability results from the binding of 
one or more Ca 2+ ions to the Rnalp molecule. It seems likely 
that the Ca 2+ binding site(s) reside in the cluster of acidic amino 
acids present in the C-terminal extensions, as similar clusters 
of acidic residues have been described to provide low affinity 
Ca 2+ sites in other proteins, e.g. calreticulin [22] and calse- 
questrin [23]. Moreover, the cleavage sites for both proteases, 
c~-chymotrypsin a d endoproteinase Asp-N, are located in or 
close to the highly acidic stretch in the C-terminal extension, 
and their accessibility is likely to be affected by a direct binding 
of Ca 2+ in the close neighbourhood. 
4. Discussion 
The product of the RNA1 gene from S. cerevisiae has long 
been implicated in the processing and/or the nucleocytoplasmic 
transport of different classes of RNA [1,24-26]. Although the 
molecular basis of the Rnalp action is not known so far, the 
recent identification of leucine-rich repeats (LRRs) in both 
S. cerevisiae [8] and S. pombe [5] Rnalp suggests that Rnalp 
exerts its function through (a) LRR-mediated protein-pro- 
tein interaction(s). LRRs, identified in a growing number of 
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proteins otherwise diverse in function and cellular localisation, 
have been proposed to represent a versatile binding motif medi- 
ating high affinity protein-protein i teractions (for review see 
[16]). This hypothesis i supported by the recently determined 
crystal structure of the RNase inhibitor, a protein composed 
entirely of LRRs [15]. The LRRs in this protein form ,8-~ 
structural units resulting in a non-globular, horseshoe-shaped 
structure of the molecule in which two principal elements, the 
o-helices and the fl-sheet, are available for interaction with 
other proteins. The exposed surface of the parallel fl-sheet 
could be of particular importance as such a structure, which 
usually occurs in the interior of proteins with other structural 
elements packed against it, could represent the binding site for 
protein ligands substituting for packing interactions [16]. 
Within the family of LRR proteins the LRRs present in 
Rnalp are most closely related to those in the RNase inhibitor, 
indicating that the structure of the individual f -~ units is prob- 
ably very similar in Rnalp. However, Rnalp contains addi- 
tional sequence elements, the intervening repeats and the 
C-terminal extension, which most likely alter the regular struc- 
ture of the RNase inhibitor. Our proteolysis tudies indicate 
that the C-terminal extension is indeed easily accessible, most 
likely forming a domain separate from the LRRs and residing 
on the surface of the molecule. This interpretation is in line with 
the fact that the majority of the amino acids found in the 
C-terminal region are the charged residues glutamate or aspar- 
tare. Moreover, while LRRs of identical length and number are 
present in the murine Rnalp homologue, fug l ,  this protein 
contains an additional 200 amino acids added C-terminally, i.e. 
has an extended C-terminal domain [6]. Although the func- 
tional properties of the C-terminal extension have not been 
described for the yeast or the murine protein, it is interesting 
to note that a deletion of this C-terminal region in S. cerevisiae 
Rnalp results in the loss of viability of the respective mutant 
cells [4]. 
In contrast to the C-terminal domain the intervening repeats 
that are inserted after the first and third LRR of all Rnalp 
species known so far are not particularly exposed to proteolytic 
attack. Even prolonged treatment of the protein with endopro- 
teinase Asp-N, ~z-chymotrypsin (Fig. 2), endoproteinase Glu-C, 
and trypsin (not shown) does not result in a cleavage in or close 
to the intervening repeats. This indicates that the intervening 
sequences either form (a) separate but compact structural do- 
main(s) or are embedded in the structure of the LRRs. 
The domain structure of Rnalp suggests that the protein 
could be involved in several functional interactions. One could 
be mediated through the LRRs, in particular through the non- 
consensus residues of the repeats. Likewise the intervening 
repeats could specify the association of certain ligands in con- 
junction with the neighbouring LRRs. Moreover, the unique 
C-terminal extension could direct Rnalp to (a) ligand(s) within 
the cell. Such ligands could be located at the nuclear pore 
complex as a conditionally lethal mutation in the nup 1 gene 
which encodes a nucleoporin in S. cerevisiae becomes ynthet- 
ically lethal in combination with the rna 1-I mutation [27]. 
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